Dual Action Cherry Cough Suppressant Oral Anesthetic Lozenge
NDC Package 54305-331-75

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Dual Action Cherry Cough Suppressant Oral Anesthetic (menthol) lozenges is adults and children 6 years and older:  dissolve 1 drop slowly in the mouth.  Repeat every 2 hours as needed or as directed by a doctorchildren under 6 years: ask a doctor. This formulation utilizes a lozenge delivery system. Marketed by Ricola Ag, this product is identified by NDC 54305-331 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
54305-331-75
Package Description
175 LOZENGE in 1 BAG
Product Code
54305-331
11-Digit Billing Format
54305033175
RxNorm Crosswalk
RxCUI: 1232117 - menthol 8.5 MG Oral Lozenge

Clinical Specifications

Proprietary Name
Dual Action Cherry Cough Suppressant Oral Anesthetic
Non-Proprietary Name
Menthol
Substance Name
Menthol
Dosage Form
Lozenge - A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
MENTHOL 8.5 mg/1
Usage Information
Adults and children 6 years and older:  dissolve 1 drop slowly in the mouth.  Repeat every 2 hours as needed or as directed by a doctorchildren under 6 years: ask a doctor

Regulatory & Marketing

Labeler Name
Ricola Ag
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-03-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (54305-331). Click a package code to view its specific billing and regulatory data.

54305-331-19
19 LOZENGE in 1 BAG
54305-331-26
26 LOZENGE in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54305-331-75 identifies a specific commercial package of 175 lozenge in 1 bag of Dual Action Cherry Cough Suppressant Oral Anesthetic, a human over the counter drug labeled by Ricola Ag. This lozenge is formulated for oral use and contains menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ricola Ag on April 03, 2011. The current certification is valid through December 31, 2026.

How is this Ricola Ag product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54305033175. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54305-331-75
11-Digit CMS (5-4-2)
54305-0331-75

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.